4 results on '"Voellenkle, Christine"'
Search Results
2. Dysregulation of microRNA expression in diabetic skin.
- Author
-
Baldini, Enke, Testa, Erika, Voellenkle, Christine, Domenico, Emanuela De, Cianfarani, Francesca, Martelli, Fabio, Ulisse, Salvatore, and Odorisio, Teresa
- Subjects
- *
MICRORNA , *SKIN , *PEOPLE with diabetes , *OXIDATIVE stress , *GENE expression - Abstract
• Molecular mechanisms underlying skin alterations in diabetes are largely unknown. • A general down-regulation of miRNA baseline expression was found in diabetic skin. • Down-regulated miRNAs control pathways involved in skin homeostasis. • Altered expression also involved pri-miRNAs and miRNA biogenesis genes. • These molecular defects likely contribute to diabetic skin manifestations. Clinical skin manifestations are common in diabetes; however, molecular mechanisms underlying such defects are largely unknown. Several findings indicate a role for microRNAs (miRNAs) in skin homeostasis. To investigate whether miRNA expression is altered in diabetic skin. Type 1 and 2 mouse models of diabetes were used. MiRNA profiling was performed on RNA extracted from the skin of type 1 diabetic mice and non-diabetic controls. Expression levels of pri-miRNAs and of miRNA-biogenesis genes were also analyzed. Biogenesis gene expression analysis was performed in human dermal fibroblasts cultured in hyperglycemic, hypoxic or oxidative stress conditions. Several miRNAs were differentially expressed in diabetic skin with a general down-modulation as compared to controls. Bioinformatics analysis of signature-miRNA target genes showed the enrichment in pathways involved in skin homeostasis, such as TGF-β and Wnt. MiRNA alteration in diabetic skin associated with reduced expression levels of DROSHA, DGCR8, XPO5, DICER1, AGO2, both as mRNA and protein. Reduced biogenesis gene expression did not correlate with accumulation of pri-miRNAs, which displayed differences in expression levels similar to those found for their mature miRNAs. Experiments with cultured fibroblasts showed that hypoxia and oxidative stress induced the down-regulation of miRNA-biogenesis genes in this skin cell type. A general down-regulation of differentially expressed miRNAs was found in diabetic skin. This alteration is part of and is dependent from a wider transcriptional defect also affecting the expression of pri-miRNAs and of genes responsible for miRNA biogenesis. Such an alteration is likely contributing to diabetic skin manifestations. [ABSTRACT FROM AUTHOR]
- Published
- 2020
- Full Text
- View/download PDF
3. Transcriptional Profiling of Hmgb1-Induced Myocardial Repair Identifies a Key Role for Notch Signaling.
- Author
-
Limana, Federica, Esposito, Grazia, Fasanaro, Pasquale, Foglio, Eleonora, Arcelli, Diego, Voellenkle, Christine, Di Carlo, Anna, Avitabile, Daniele, Martelli, Fabio, Antonio Russo, Matteo, Pompilio, Giulio, Germani, Antonia, and C Capogrossi, Maurizio
- Subjects
- *
MYOCARDIAL infarction , *ANIMAL models in research , *GENE expression , *GENETIC regulation , *REGENERATION (Biology) - Abstract
Exogenous high-mobility group box 1 protein (HMGB1) administration to the mouse heart, during acute myocardial infarction (MI), results in cardiac regeneration via resident c-kit+ cell (CPC) activation. Aim of the present study was to identify the molecular pathways involved in HMGB1-induced heart repair. Gene expression profiling was performed to identify differentially expressed genes in the infarcted and bordering regions of untreated and HMGB1-treated mouse hearts, 3 days after MI. Functional categorization of the transcripts, accomplished using Ingenuity Pathway Analysis software (IPA), revealed that genes involved in tissue regeneration, that is, cardiogenesis, vasculogenesis and angiogenesis, were present both in the infarcted area and in the peri-infarct zone; HMGB1 treatment further increased the expression of these genes. IPA revealed the involvement of Notch signaling pathways in HMGB1-treated hearts. Importantly, HMGB1 determined a 35 and 58% increase in cardiomyocytes and CPCs expressing Notch intracellular cytoplasmic domain, respectively. Further, Notch inhibition by systemic treatment with the γ-secretase inhibitor DAPT, which blocked the proteolytic activation of Notch receptors, reduced the number of CPCs, their proliferative fraction, and cardiomyogenic differentiation in HMGB1-treated infarcted hearts. The present study gives insight into the molecular processes involved in HMGB1-mediated cardiac regeneration and indicates Notch signaling as a key player.Molecular Therapy (2013); 21 10, 1841-1851. doi:10.1038/mt.2013.137 [ABSTRACT FROM AUTHOR]
- Published
- 2013
- Full Text
- View/download PDF
4. ChIP-on-Chip Analysis of In Vivo Mutant p53 Binding To Selected Gene Promoters.
- Author
-
Dell'Orso, Stefania, Fontemaggi, Giulia, Stambolsky, Perry, Goeman, Frauke, Voellenkle, Christine, Levrero, Massimo, Strano, Sabrina, Rotter, Varda, Oren, Moshe, and Blandino, Giovanni
- Subjects
- *
P53 protein , *GENETIC mutation , *CARCINOGENESIS , *GENE expression , *PROMOTERS (Genetics) , *CHROMATIN , *BREAST cancer , *GENETIC transcription - Abstract
Growing evidence shows that mutant p53 proteins, which are present in many human tumors, gain oncogenic activities that can actively contribute to tumorigenesis. Mutant p53 proteins have been extensively shown to affect the expression of several genes involved in various aspects of cancer biology. We show here the ChIP-on-chip analysis of mutant p53 binding to a set of 154 promoters, composed of both validated and putative mutant p53 target genes. By using the chromatin obtained from mutant p53R175H-immunoprecipitation in proliferating SKBr3 breast cancer cells, we found that mutant p53 binds to 40 of the 154 promoters analyzed. siRNA-mediated mutant p53 knock-down modulates the transcript abundance of some of these target genes. Two-thirds of the mutant p53-bound promoters were also engaged by either p300 or PCAF acetyl-transferases, strongly indicating the presence of transcriptionally active complexes. We also found that NF-kB binding sites are overrepresented among the mutant p53-bound promoters; a ChIP-on-chip analysis confirmed that NF-kB p65 binds to 27 of the mutant p53-bound promoters, indicating that mutant p53 could influence the transcriptional output of these NF-kB target genes. [ABSTRACT FROM AUTHOR]
- Published
- 2011
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.